IL-4 inhibits the migration of human Langerhans cells through the downregulation of TNF receptor II expression

Journal of Investigative Dermatology

Volumn 113, Issue 4, 1999, Pages 541-546

  Takayama, Kaoru ^a   Yokozeki, Hiroo ^a   Ghoreishi, Mehran ^a   Satoh, Takahiro ^a   Katayama, Ichiro ^b   Umeda, Tadashi ^a   Nishioka, Kiyoshi ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemotaxis; Contact sensitivity; Cytokines; Langerhans cell; Migration

Indexed keywords

GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LANGERHANS CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DOWN REGULATION;

EID: 0032831953     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1747.1999.00629.x     Document Type: Article

References (34)

1. Asada H, Linton J, Katz SI: Cytokine gene expression during the elucidation phase of contact sensitivity: regulation by endogenous IL-4. J Invest Dermatol 108:406-411, 1997
2. Cumberbatch M, Kimber I: Phenotypic characteristics of antigen-bearing cells in the draining lymph nodes of contact sensitized mice. Immunol 71(3):404-410, 1990
3. Cumberbatch M, Kimber I: Dermal tumor necrosis factor-alpha induces dendritic cell migration to draining lymph nodes and possibly provides one stimulus for Langerhans Cell migration. Immunol 75(2):257-263, 1992
4. Cumberbatch M, Fielding I, Kimber I: Modulation of epidermal Langerhans' Cell frequency by tumour necrosis factor-alpha. Immunol 81(3)-395-401, 1994
5. Falk W, Goodwin RH Jr, Leonard EJ: A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J Immunol Meth 33:329-333, 1980
6. Foster CA, Yokozeki H, Rappersberger K, et al.: Human epidermal T cells predominately belong to the lineage expressing α / β T cell receptor. J Exp Med 171:997-1013, 1990
7. Frelinger JG, Hood L, Hill S, Frelinger JA: Mouse epidermal Ia molecules have a bone marrow origin. Natute 282:321-323. 1979
8. Gautam SC, Chikkala NF, Hamilton TA: Anti-inflammatory action of IL-4. Negative regulation of contact sensitivity to Trinitrochlorobenzene. J Immunol 148:1411-1415, 1992
9. Halliday GM, Lucas AD: Control of Langerhans' cell density by a skin tumor-derived cytokine. Immunol 77(1); 13-18, 1992
10. Hart PH, Hunt EM, Bonder CS, Watoson CJ, Finlay-Jones JJ: Regulation of surface and soluble TNF receptor expression on human monocytes and synovial fluid macrophages by IL-4 and IL-10. J Immunol 157:3672-3680, 1996
11. Jensen ER, Prince HE: Culture-associated enhancement of LECAM-1 expression by lymphocytes and partial inhibition of enhancement by IL-4. Immunol Invest 21: 47-63, 1992
12. Junghans V, Jung T, Neumann C: Human keratinocytes constitutively express IL-4 receptor molecules and respond to IL-4 with an increase in B7/BB1 expression. Exp Dermatol 5:316-324, 1996
13. Kaplan G, Walsh G, Guido LS, et al.: Novel responses of human skin to intradermal recombinant granulocyte/macrophage colony-stimulating factor: Langerhans cell recruitment, keratinocyte growth, and enhanced wound healing. J Exp Med 175:1717-1728, 1992
14. Katz SI, Tamaki K, Sachs DH: Epidermal Langerhans cells are derived from cells originating in bone marrow. Nature 282:324, 1979
15. Kobayashi V, Staquer M-J, Dezutter-Dambuyant C, Schmitt D: Development of motility of Langerhans cell through extracellular matrix by in vitro hapten contact. Eur J Immunol 24:2254-2257, 1994
16. Kripke ML, Munn CG, Jeevan A, Tang JM, Bucana C: Evidence that cutaneous antigen-presenting cells migrate to regional lymph nodes during contact sensitization. J Immunol 145:2833-2838, 1990
17. Macatonia SE, Knight SC, Edwards AJ, Griffiths S, Fryer P: Localization of antigen on lymph node dendritic cells after exposure to the contact sensitizer fluorescein isothiocyanate. J Exp Med 166;1654-1667, 1987
18. Ma J, Wang J-H, Guo Y-J, Sy M-S, Bigby M: In vivo treatment with anti-ICAM-1 and anti-LFA-1 antibodies inhibits contact sensitization-induced migration of epidermal Langerhans cells to regional lymph nodes. Cellular Immunol 158:389-399, 1994
19. Rambukkana A, Pistoor FHM, Bos JD, Kapsenberg ML, Das PK: Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1 β. Lab Invest 74:422-436, 1996
20. Ryffel B, Brockhaus M, Geoner B, Mihatsch MJ, Gudat F: Tumor necrosis factor receptor distribution in human lymphoid tissue. Immunol 74:446-452, 1991
21. Richters CD, Reits EA, Van Pelt AM, Hoekstra MJ, Van Baare J, Du pont JS, Kamperdijk EWA: Effect of low-dose UVB irradiation on the migration properties and functional capacities of human skin dendritic cells. Clin Exp Immunol 104:191-197, 1996
22. Rupec R, Magerstaedt R, Schirren CG, Sander E, Bieber T: Granulocyte/ macrophage-colony-stimulating factor induces the migration of human epidermal Langerhans cells in vitro. Exp Dermatol 5:115-119, 1996
23. Sallusto F, Lanzavecchia A: Efficient presentation of soluble antigen by cultured human dendritic cell is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and down-regulated by tumor necrosis factor alpha. J Exp Med 179:1109-1118, 1994
24. Schwarzenberger K, Udey MC: Contact allergens and epidermal proinflammatory cytokines modulate Langerhans cell E-cadherin expression in situ. J Invest Dermatol 106:553-558, 1996
25. Silberberg-Sinakin I, Thorbecke GJ, Baer RL, Rosenthal SA, Berezowsky V: Antigen-hearing Langerhans cells in skin, dermal lymphocytics and in lymph nodes. Cell Immunol 25:167-151, 1976
26. Stingl G, Gazze-Stingl LA, Aberer W, Wolff K: Antigen presentation by murine epidermal Langerhans cells and its alteration by ultraviolet B light. J Immunol 127:1707-1712, 1981
27. Stingl G, Katz SI, Clement L, Green I, Shevach EM: Immunologic function of Ia-bearing epidermal Langerhans cells. J Immunol 121:2005-2013, 1978
28. Stingl G Wolff-Schreiner EC, Pichler WJ, Gschnait F, Knapp W, Wolff K: Epidermal Langerhans cells bear Fc and C3 receptors. Nature 268:245-246, 1977
29. Tang A, Amagai M, Granger G, Stanley R, Udey MC: Adhesion of epidermis Langerhans cells to keratinocytes mediated by E-cadherin. Nature 361:82-85, 1993
30. Wang B, Fujisawa H, Zhuang L, et al.: Depressed Langerhans cell migration and reduced contact hypersensitivity response in mice lacking TNF receptor p75. J Immunol 159:6148-6155, 1997
31. Yamazaki S, Katayama I, Yokozeki H, Satoh T, Nishioka K: Production of chemotactic factor(s) of Langerhans cells by lymph node cells in contact sensitivity. J Dermatol Sci 11(1): 51-58, 1996
32. Yamazaki S, Yokozeki H, Satoh T, Katayama I, Nishioka K: TNF-α, RANTES, and MCP-1 are major chemoattractants of murine Langerhans cells to the regional lymph nodes. Exp Dermatol 7(1):35-41, 1998
33. Yang Y, Yoo HM, Choi I, Pyun KH, Hyun SM, Ha H: Interleukin 4-induced proliferation in normal human keratinocytes is associated with c-myc gene expression and inhibition by genistein. J Invest Dermatol 107:367-372, 1996
34. Yokozeki H, Takayama K, Ohki O, Satoh T, Umeda T, Katayama I, Nishioka K: Interferon-gamma differentially regulates CD80(B7-1) and CD86(B7-2/B70) expression on human Langerhans cells. Br J Dermatol 136:831-837, 1997